Professor Marcelo Rivolta
Founder and Chief Scientific Officer
Marcelo is a globally recognised Professor of Sensory Stem Cell Biology. He has been based at Sheffield University in the UK since 2001 and has written over 40 papers on the subject, many of which have been published in peer-review journals. The Rivolta Laboratory, which he established at Sheffield University, is dedicated to studying the biology and behaviour of auditory stem cells, and to exploring their potential to regenerate the damaged inner ear.
Read more
Dr. Simon Chandler
Chief Executive Officer
Simon is CEO of Rinri Therapeutics, responsible for the strategic direction and operation of the company. He has been involved since its inception and works closely with Marcelo Rivolta, Rinri’s founder.
Read more
Dr. Terri Gaskell
Chief Operating Officer
Terri has over 20 years of research and development experience within life sciences, in both academic and industry roles, with a focus on the development and translation of cell and gene-based therapies.
Read more
Professor Doug Hartley
Chief Medical Officer
Doug is a Professor of Otology at Nottingham University and a consultant ENT surgeon at Nottingham University Hospital’s NHS Trust – Queen’s Medical Centre. He qualified, with distinction, from Newcastle Medical School in 1995, and was awarded a DPhil from Oxford University in the field of hearing research in 2001.
Read more
Rachel Haines
Director of Clinical Operations
Rachel Haines joined Rinri Therapeutics as Director of Clinical Operations in October 2022. She is a hearing scientist by training and has worked in translational research and clinical trials within both the domestic and international markets and public and private sectors since 2007.
Read more
Dr. Faizah Mushtaq
Clinical Director
Faizah is a clinically qualified audiologist who has previously provided hearing care to patients within both NHS and private settings. Subsequent completion of an MSc in Cognitive Neuroscience facilitated her transition from a clinician into a researcher and prepared her with the skills required to study for a doctorate (PhD) in translational hearing research.
Read more
Professor Marcelo Rivolta
Founder and Chief Scientific Officer
Marcelo is a globally recognised Professor of Sensory Stem Cell Biology. He has been based at Sheffield University in the UK since 2001 and has written over 40 papers on the subject, many of which have been published in peer-review journals. The Rivolta Laboratory, which he established at Sheffield University, is dedicated to studying the biology and behaviour of auditory stem cells, and to exploring their potential to regenerate the damaged inner ear.
Read more
Dr. Simon Chandler
Chief Executive Officer
Simon is CEO of Rinri Therapeutics, responsible for the strategic direction and operation of the company. He has been involved since its inception and works closely with Marcelo Rivolta, Rinri’s founder.
Read more
Dr. Terri Gaskell
Chief Operating Officer
Terri has over 20 years of research and development experience within life sciences, in both academic and industry roles, with a focus on the development and translation of cell and gene-based therapies.
Read more
Professor Doug Hartley
Chief Medical Officer
Doug is a Professor of Otology at Nottingham University and a consultant ENT surgeon at Nottingham University Hospital’s NHS Trust – Queen’s Medical Centre. He qualified, with distinction, from Newcastle Medical School in 1995, and was awarded a DPhil from Oxford University in the field of hearing research in 2001.
Read more
Rachel Haines
Director of Clinical Operations
Rachel Haines joined Rinri Therapeutics as Director of Clinical Operations in October 2022. She is a hearing scientist by training and has worked in translational research and clinical trials within both the domestic and international markets and public and private sectors since 2007.
Read more
Dr. Faizah Mushtaq
Clinical Director
Faizah is a clinically qualified audiologist who has previously provided hearing care to patients within both NHS and private settings. Subsequent completion of an MSc in Cognitive Neuroscience facilitated her transition from a clinician into a researcher and prepared her with the skills required to study for a doctorate (PhD) in translational hearing research.
Read more
Professor Marcelo Rivolta
Founder and Chief Scientific Officer
Marcelo is a globally recognised Professor of Sensory Stem Cell Biology. He has been based at Sheffield University in the UK since 2001 and has written over 40 papers on the subject, many of which have been published in peer-review journals. The Rivolta Laboratory, which he established at Sheffield University, is dedicated to studying the biology and behaviour of auditory stem cells, and to exploring their potential to regenerate the damaged inner ear.
Read more
Dr. Simon Chandler
Chief Executive Officer
Simon is CEO of Rinri Therapeutics, responsible for the strategic direction and operation of the company. He has been involved since its inception and works closely with Marcelo Rivolta, Rinri’s founder.
Read more
Dr. Terri Gaskell
Chief Operating Officer
Terri has over 20 years of research and development experience within life sciences, in both academic and industry roles, with a focus on the development and translation of cell and gene-based therapies.
Read more
Professor Doug Hartley
Chief Medical Officer
Doug is a Professor of Otology at Nottingham University and a consultant ENT surgeon at Nottingham University Hospital’s NHS Trust – Queen’s Medical Centre. He qualified, with distinction, from Newcastle Medical School in 1995, and was awarded a DPhil from Oxford University in the field of hearing research in 2001.
Read more
Rachel Haines
Director of Clinical Operations
Rachel Haines joined Rinri Therapeutics as Director of Clinical Operations in October 2022. She is a hearing scientist by training and has worked in translational research and clinical trials within both the domestic and international markets and public and private sectors since 2007.
Read more
Dr. Faizah Mushtaq
Clinical Director
Faizah is a clinically qualified audiologist who has previously provided hearing care to patients within both NHS and private settings. Subsequent completion of an MSc in Cognitive Neuroscience facilitated her transition from a clinician into a researcher and prepared her with the skills required to study for a doctorate (PhD) in translational hearing research.
Read more